A Case of Uterine Serous Carcinoma in a Patient with a Germline BRCA1 Mutation: Genomic Profiling Reveals an Ovarian Cancer-Like Molecular Signature.

Naofumi Yamane; Yusuke Matoba; Tomomi Yamazaki; Takuto Uyama; Yuka Enokizono; Kousuke Nakamoto; Katsuyuki Tomono; Yuko Teraoka; Yuriko Oomori; SUGURU NOSAKA; Yurika Mukai; IEMASA KOH; Kouji Banno; Yoshiki Kudo

doi:10.1159/000547977

December 1, 2025

A Case of Uterine Serous Carcinoma in a Patient with a Germline BRCA1 Mutation: Genomic Profiling Reveals an Ovarian Cancer-Like Molecular Signature.

View at Publisher

Ask AI

Bookmark

Share

Key Points

Genomic profiling indicates distinct molecular features in this case.
The BRCA1 mutation suggests potential differences from sporadic cases of uterine serous carcinoma.
Assessment highlights the need for further exploration into molecular characteristics of USC cases with germline mutations.
The findings imply a need for clinical attention towards patients with BRCA1 mutations and USC.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Case reveals genomic profiling of uterine serous carcinoma in a BRCA1 mutation patient, suggesting unique molecular characteristics.

Abstract

USC with a BRCA1 mutation may have molecular characteristics distinct from those of sporadic USC, and further accumulation and analysis of such cases are needed to evaluate the clinical implications.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Yamane et al. (2025) studied this question.

synapsesocial.com/papers/6930e8cdea1aef094cca3887 https://doi.org/10.1159/000547977

View at Publisher

Ask AI

Bookmark

Share

A Case of Uterine Serous Carcinoma in a Patient with a Germline BRCA1 Mutation: Genomic Profiling Reveals an Ovarian Cancer-Like Molecular Signature.

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

A Case of Uterine Serous Carcinoma in a Patient with a Germline BRCA1 Mutation: Genomic Profiling Reveals an Ovarian Cancer-Like Molecular Signature.

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading